Evidence map›Paper›PMID 26900672›Full record

ReviewCurrent opinion in psychiatry2016

Gamma band oscillations: a key to understanding schizophrenia symptoms and neural circuit abnormalities.

James M McNally, Robert W McCarley

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 1 synthesis or guideline pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Single-Dose Memantine Improves Cortical Oscillatory Response Dynamics in Patients with Schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2017
    Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Layer 6 Corticothalamic Neurons Induce High Gamma Oscillations Through Cortico-cortical and Cortico-thalamo-cortical Pathways.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  14. Article
  15. Biological psychiatry global open science · 2025
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

James M McNallyLaboratory of Neuroscience, VA Boston Healthcare System and Department of Psychiatry, Harvard Medical School, Brockton, Massachusetts, USA.
Robert W McCarley
Harvard University · US

Funding

THE SYNAPTIC BASIS OF SLEEP CYCLE CONTROLR01MH039683 · NIMH · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BROWN, RITCHIE EDWARD · 1985 to 2017
$3.8M
Sleep Spindles: Role of Thalamic Reticular Nucleus and Parvalbumin GABA NeuronsI01BX001356 · VA · VA BOSTON HEALTH CARE SYSTEM · PI BROWN, RITCHIE EDWARD · 2012 to 2020
–
Neurophysiological and MRI Studies of SchizophreniaI01CX000157 · VA · VA BOSTON HEALTH CARE SYSTEM · PI NIZNIKIEWICZ, MARGARET A · 2009 to 2018
–
Improving cortical function & cognition in schizophrenia by modulation of mGluR5IK2BX002130 · VA · VA BOSTON HEALTH CARE SYSTEM · PI MCNALLY, JAMES M · 2014 to 2018
–
BLRD VA I01 BX001356BLRD VA IK2 BX002130CSRD VA I01 CX000157NIMH NIH HHS R01 MH039683
6 · The paper itself

Abstract

purpose of reviewWe review our current understanding of abnormal γ band oscillations in schizophrenia, their association with symptoms and the underlying cortical circuit abnormality, with a particular focus on the role of fast-spiking parvalbumin gamma-aminobutyric acid (GABA) neurons in the disease state. RECENT

findingsClinical electrophysiological studies of schizophrenia patients and pharmacological models of the disorder show an increase in spontaneous γ band activity (not stimulus-evoked) measures. These findings provide a crucial link between preclinical and clinical work examining the role of γ band activity in schizophrenia. MRI-based experiments measuring cortical GABA provides evidence supporting impaired GABAergic neurotransmission in schizophrenia patients, which is correlated with γ band activity level. Several studies suggest that stimulation of the cortical circuitry, directly or via subcortical structures, has the potential to modulate cortical γ activity, and improve cognitive function. SUMMARY: Abnormal γ band activity is observed in patients with schizophrenia and disease models in animals, and is suggested to underlie the psychosis and cognitive/perceptual deficits. Convergent evidence from both clinical and preclinical studies suggest the central factor in γ band abnormalities is impaired GABAergic neurotransmission, particularly in a subclass of neurons which express parvalbumin. Rescue of γ band abnormalities presents an intriguing option for therapeutic intervention.

Indexed as

Synaptic TransmissionAnimalsCognition Disordersgamma-Aminobutyric AcidHumansNeuronsParvalbuminsPsychotic DisordersSchizophreniaSchizophrenic Psychologygamma-Aminobutyric AcidParvalbumins

Identifiers

PMID26900672
PMCPMC4901383
OpenAlexW2330883635

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.